1. Home
  2. INOD vs ORKA Comparison

INOD vs ORKA Comparison

Compare INOD & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innodata Inc.

INOD

Innodata Inc.

HOLD

Current Price

$65.01

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

HOLD

Current Price

$26.69

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INOD
ORKA
Founded
1988
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
INOD
ORKA
Price
$65.01
$26.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$91.67
$48.20
AVG Volume (30 Days)
953.9K
713.6K
Earning Date
02-19-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
62.46
N/A
EPS
1.01
N/A
Revenue
$238,467,000.00
N/A
Revenue This Year
$48.85
N/A
Revenue Next Year
$25.93
N/A
P/E Ratio
$61.42
N/A
Revenue Growth
73.57
N/A
52 Week Low
$26.41
$5.49
52 Week High
$93.85
$32.64

Technical Indicators

Market Signals
Indicator
INOD
ORKA
Relative Strength Index (RSI) 66.52 38.76
Support Level $50.90 $25.23
Resistance Level $55.18 $32.64
Average True Range (ATR) 3.05 2.19
MACD 1.65 -0.59
Stochastic Oscillator 97.97 18.76

Price Performance

Historical Comparison
INOD
ORKA

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: